1 INTRODUCTION
1.1 OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 MARKET SCOPE
1.3 RESEARCH METHODOLOGY
1.3.1 SECONDARY DATA
1.3.2 PRIMARY DATA
1.3.3 MARKET SIZE ESTIMATION
1.3.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.4 STAKEHOLDERS
1.5 CURRENCY
1.6 RESEARCH ASSUMPTIONS
1.7 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 DROC MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 COST STRUCTURE ANALYSIS
3.6 VALUE CHAIN ANALYSIS
3.7 COVID-19 IMPACT ANALYSES
4 INDUSTRY TRENDS
4.1 INTRODUCTION
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES MODEL
4.3.1 DEGREE OF COMPETITION
4.3.2 BARGAINING POWER OF BUYERS
4.3.3 BARGAINING POWER OF SUPPLIERS
4.3.4 THREAT FROM SUBSTITUTES
4.3.5 THREAT FROM NEW ENTRANTS
5 3D CELL CULTURE TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2017-2021
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 SCAFFOLD FREE PLATFORMS
5.5.1 HANGING DROP MICROPLATES
5.5.2 SPHEROID MICROPLATES WITH ULA COATING
5.5.3 MAGNETIC LEVITATION AND 3D BIOPRINTING
5.5.4 3D PETRI DISHES
5.6 GELS
5.7 BIOREACTORS
5.8 MICROFLUIDIC 3D CELL CULTURE
5.9 SERVICES
5.10 SCAFFOLD BASED PLATFORMS
5.10.1 MACRO-SCALE
5.10.2 MICRO-SCALE
5.10.3 NANO-SCALE
5.10.4 SOLID SCAFFOLDS
6 3D CELL CULTURE MARKET END USE ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET END USE ANALYSIS, 2017-2021
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
6.6 CONTRACT RESEARCH LABORATORIES
6.7 ACADEMIC INSTITUTES
6.8 HOSPITALS AND DIAGNOSTIC CENTERS
6.9 OTHERS
7 3D CELL CULTURE MARKET APPLICATION ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2017-2021
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 CANCER RESEARCH
7.6 STEM CELL RESEARCH
7.7 DRUG DISCOVERY
7.8 REGENERATIVE MEDICINE
7.9 OTHERS
8 GLOBAL 3D CELL CULTURE REGIONAL ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
8.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
8.2.3 Y-O-Y GROWTH TREND ANALYSIS
8.2.3.1 U.S.
8.2.3.2 Canada
8.2.3.3 Mexico
8.3 ASIA-PACIFIC
8.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
8.3.2 Y-O-Y GROWTH TREND ANALYSIS
8.3.2.1 China
8.3.2.2 Japan
8.3.2.3 Korea
8.3.2.4 India
8.3.2.5 Southeast Asia
8.4 MIDDLE EAST AND AFRICA
8.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
8.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
8.4.3 Y-O-Y GROWTH TREND ANALYSIS
8.4.3.1 Saudi Arabia
8.4.3.2 UAE
8.4.3.3 Egypt
8.4.3.4 Nigeria
8.4.3.5 South Africa
8.5 EUROPE
8.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
8.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
8.5.3 Y-O-Y GROWTH TREND ANALYSIS
8.5.3.1 Germany
8.5.3.2 France
8.5.3.3 UK
8.5.3.4 Russia
8.5.3.5 Italy
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2017-2021
8.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2022–2031
8.6.3 Y-O-Y GROWTH TREND ANALYSIS
8.6.3.1 Brazil
8.6.3.2 Argentina
8.6.3.3 Columbia
9 COUNTRY LEVEL ANALYSIS
9.1 UNITED STATES
9.2 CANADA
9.3 MEXICO
9.4 CHINA
9.5 JAPAN
9.6 INDIA
9.7 KOREA
9.8 SAUDI AREBIA
9.9 UAE
9.10 EGYPT
9.11 NIGERIA
9.12 SOUTH AFRICA
9.13 GERMANY
9.14 FRANCE
9.15 UK
9.16 RUSSIA
9.17 ITALY
9.18 BRAZIL
9.19 ARGENTINA
9.20 COLUMBIA
10 MARKET PLAYERS
10.1 SYNTHECON
10.1.1 BUSINESS OVERVIEW:
10.1.2 PRODUCT PORTFOLIO
10.1.3 RECENT DEVELOPMENTS
10.1.4 SWOT ANALYSIS:
10.2 INCORPORATED
10.3 ADVANCED BIOMATRIX, INC.
10.4 CORNING INCORPORATED
10.5 THERMO FISHER SCIENTIFIC INC.
10.6 MERCK & CO., INC.
10.7 AVANTOR, INC.
10.8 INSPHERO AG
10.9 BECTON, DICKINSON AND COMPANY
10.10 LONZA GROUP LTD.
10.11 3D BIOTEK LLC
10.12 PROMOCELL GMBH
10.13 TECAN TRADING AG
10.14 REPROCELL INC.
10.15 CN BIO INNOVATIONS LTD
10.16 LENA BIOSCIENCES
10.17 GREINER BIO-ONE INTERNATIONAL GMBH
10.18 SARTORIUS AG
10.19 NANO3D BIOSCIENCES, INC.
10.20 MIMETAS B.V.
10.21 QGEL SA
10.22 TISSUSE GMBH
10.23 SUNVIVO INC.
11 ABOUT US

TABLE 1 3D CELL CULTURE REGIONAL HISTORICAL MARKET ANALYSIS, 2017–2021 (USD MILLION)
TABLE 2 GLOBAL 3D CELL CULTURE MARKET, 2022–2031, (USD MILLION)
TABLE 3 3D CELL CULTURE CURRENT AND FUTURE REGIONAL ANALYSIS, 2022–2031 (USD MILLION)
TABLE 4 GLOBAL 3D CELL CULTURE HISTORICAL MARKET TYPE ANALYSIS, 2017-2021, (USD MILLION)
TABLE 5 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 6 GLOBAL 3D CELL CULTURE HISTORICAL MARKET END USE ANALYSIS, 2017-2021, (USD MILLION)
TABLE 7 3D CELL CULTURE CURRENT AND FUTURE END USE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 8 GLOBAL 3D CELL CULTURE HISTORICAL MARKET APPLICATION ANALYSIS, 2017-2021, (USD MILLION)
TABLE 9 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 10 NORTH AMERICA 3D CELL CULTURE HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 11 NORTH AMERICA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 12 NORTH AMERICA 3D CELL CULTURE CURRENT AND FUTURE END USE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 13 NORTH AMERICA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 14 U.S. 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2017–2023
TABLE 15 U.S. 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 16 U.S. 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 17 CANADA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 18 CANADA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 19 MEXICO 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 20 MEXICO 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 21 APAC 3D CELL CULTURE HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 22 ASIA-PACIFIC 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 23 ASIA-PACIFIC 3D CELL CULTURE CURRENT AND FUTURE END USE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 24 ASIA-PACIFIC 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 25 CHINA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 26 CHINA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 27 JAPAN 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 28 JAPAN 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 29 KOREA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 30 KOREA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 31 INDIA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 32 INDIA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 33 SOUTHEAST ASIA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 34 SOUTHEAST ASIA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA 3D CELL CULTURE HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA 3D CELL CULTURE CURRENT AND FUTURE END USE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 39 SAUDI ARABIA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 40 SAUDI ARABIA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 41 UAE 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 42 UAE 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 43 EGYPT 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 44 EGYPT 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 45 NIGERIA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 46 NIGERIA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 47 SOUTH AFRICA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 48 SOUTH AFRICA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 49 EUROPE 3D CELL CULTURE HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 50 EUROPE 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 51 EUROPE 3D CELL CULTURE CURRENT AND FUTURE END USE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 52 EUROPE 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 53 GERMANY 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 54 GERMANY 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 55 FRANCE 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 56 FRANCE 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 57 UK 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 58 UK 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 59 RUSSIA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 60 RUSSIA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 61 ITALY 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 62 ITALY 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 63 SOUTH AMERICA 3D CELL CULTURE HISTORICAL MARKET ANALYSIS, 2017-2021, (USD MILLION)
TABLE 64 SOUTH AMERICA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 65 SOUTH AMERICA 3D CELL CULTURE CURRENT AND FUTURE END USE ANALYSIS, 2022–2031 (USD MILLION)
TABLE 66 SOUTH AMERICA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031 (USD MILLION)
TABLE 67 BRAZIL 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 68 BRAZIL 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 69 ARGENTINA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 70 ARGENTINA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)
TABLE 71 COLUMBIA 3D CELL CULTURE CURRENT AND FUTURE TYPE ANALYSIS, 2022–2031, (USD MILLION)
TABLE 72 COLUMBIA 3D CELL CULTURE CURRENT AND FUTURE APPLICATION ANALYSIS, 2022–2031, (USD MILLION)